Curative strategy for smoldering multiple myeloma: GEM-CESAR - 101793

Spotlight
Video

Curative strategy for smoldering multiple myeloma: GEM-CESAR

VJHemOnc has 1608 videos Subscribe Here

Loading........
Description: In this exciting interview from the American Society of Hematology (ASH) 2017 Annual Meeting and Exposition in Atlanta, GA, Maria-Victoria Mateos, MD, PhD, of the University Hospital of Salamanca, Salamanca, Spain, discusses the GEM-CESAR study (NCT02415413). This trial investigates a curative strategy for high-risk smoldering multiple myeloma (SMM), consisting of induction with carfilzomib, lenalidomide and dexamethasone (KRd), followed by HDT-ASCT, consolidation with KRd and maintenance with Rd. Dr Mateos discusses the logic behind this strategy, the results of the study in terms of progression to MM, response rates, MRD, overall survival and the safety profile of the regimen.
Shared By : VJHemOnc
Posted on : 01/09/18
Added : 11 months ago
Category : Multiple Myeloma